229 related articles for article (PubMed ID: 32476252)
1. Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes.
Coomans de Brachène A; Castela A; Op de Beeck A; Mirmira RG; Marselli L; Marchetti P; Masse C; Miao W; Leit S; Evans-Molina C; Eizirik DL
Diabetes Obes Metab; 2020 Oct; 22(10):1827-1836. PubMed ID: 32476252
[TBL] [Abstract][Full Text] [Related]
2. Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.
Dos Santos RS; Guzman-Llorens D; Perez-Serna AA; Nadal A; Marroqui L
Front Immunol; 2023; 14():1263926. PubMed ID: 37854597
[TBL] [Abstract][Full Text] [Related]
3. Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes.
Marroqui L; Dos Santos RS; Op de Beeck A; Coomans de Brachène A; Marselli L; Marchetti P; Eizirik DL
Diabetologia; 2017 Apr; 60(4):656-667. PubMed ID: 28062922
[TBL] [Abstract][Full Text] [Related]
4. TYK2, a Candidate Gene for Type 1 Diabetes, Modulates Apoptosis and the Innate Immune Response in Human Pancreatic β-Cells.
Marroqui L; Dos Santos RS; Fløyel T; Grieco FA; Santin I; Op de Beeck A; Marselli L; Marchetti P; Pociot F; Eizirik DL
Diabetes; 2015 Nov; 64(11):3808-17. PubMed ID: 26239055
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice.
Syed F; Ballew O; Lee CC; Rana J; Krishnan P; Castela A; Weaver SA; Chalasani NS; Thomaidou SF; Demine S; Chang G; Coomans de Brachène A; Alvelos MI; Marselli L; Orr K; Felton JL; Liu J; Marchetti P; Zaldumbide A; Scheuner D; Eizirik DL; Evans-Molina C
bioRxiv; 2024 May; ():. PubMed ID: 38766166
[TBL] [Abstract][Full Text] [Related]
6. The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α.
Chandra V; Ibrahim H; Halliez C; Prasad RB; Vecchio F; Dwivedi OP; Kvist J; Balboa D; Saarimäki-Vire J; Montaser H; Barsby T; Lithovius V; Artner I; Gopalakrishnan S; Groop L; Mallone R; Eizirik DL; Otonkoski T
Nat Commun; 2022 Oct; 13(1):6363. PubMed ID: 36289205
[TBL] [Abstract][Full Text] [Related]
7. Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress.
Lombardi A; Tomer Y
J Autoimmun; 2017 Jun; 80():48-55. PubMed ID: 28238527
[TBL] [Abstract][Full Text] [Related]
8. Pro-inflammatory cytokines induce cell death, inflammatory responses, and endoplasmic reticulum stress in human iPSC-derived beta cells.
Demine S; Schiavo AA; Marín-Cañas S; Marchetti P; Cnop M; Eizirik DL
Stem Cell Res Ther; 2020 Jan; 11(1):7. PubMed ID: 31900242
[TBL] [Abstract][Full Text] [Related]
9. IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells.
Coomans de Brachène A; Dos Santos RS; Marroqui L; Colli ML; Marselli L; Mirmira RG; Marchetti P; Eizirik DL
Diabetologia; 2018 Mar; 61(3):636-640. PubMed ID: 29305625
[TBL] [Abstract][Full Text] [Related]
10. Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms.
Brozzi F; Nardelli TR; Lopes M; Millard I; Barthson J; Igoillo-Esteve M; Grieco FA; Villate O; Oliveira JM; Casimir M; Bugliani M; Engin F; Hotamisligil GS; Marchetti P; Eizirik DL
Diabetologia; 2015 Oct; 58(10):2307-16. PubMed ID: 26099855
[TBL] [Abstract][Full Text] [Related]
11. Distinct differences in the responses of the human pancreatic β-cell line EndoC-βH1 and human islets to proinflammatory cytokines.
Oleson BJ; McGraw JA; Broniowska KA; Annamalai M; Chen J; Bushkofsky JR; Davis DB; Corbett JA; Mathews CE
Am J Physiol Regul Integr Comp Physiol; 2015 Sep; 309(5):R525-34. PubMed ID: 26084699
[TBL] [Abstract][Full Text] [Related]
12. Reduced Tyk2 gene expression in β-cells due to natural mutation determines susceptibility to virus-induced diabetes.
Izumi K; Mine K; Inoue Y; Teshima M; Ogawa S; Kai Y; Kurafuji T; Hirakawa K; Miyakawa D; Ikeda H; Inada A; Hara M; Yamada H; Akashi K; Niho Y; Ina K; Kobayashi T; Yoshikai Y; Anzai K; Yamashita T; Minagawa H; Fujimoto S; Kurisaki H; Shimoda K; Katsuta H; Nagafuchi S
Nat Commun; 2015 Apr; 6():6748. PubMed ID: 25849081
[TBL] [Abstract][Full Text] [Related]
13. Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-beta in primary pro-B cells.
Gamero AM; Potla R; Wegrzyn J; Szelag M; Edling AE; Shimoda K; Link DC; Dulak J; Baker DP; Tanabe Y; Grayson JM; Larner AC
J Biol Chem; 2006 Jun; 281(24):16238-44. PubMed ID: 16601124
[TBL] [Abstract][Full Text] [Related]
14. Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic β cells.
Szymczak F; Alvelos MI; Marín-Cañas S; Castela Â; Demine S; Colli ML; Op de Beeck A; Thomaidou S; Marselli L; Zaldumbide A; Marchetti P; Eizirik DL
Sci Adv; 2022 Sep; 8(37):eabn5732. PubMed ID: 36103539
[TBL] [Abstract][Full Text] [Related]
15. Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes.
Coomans de Brachène A; Scoubeau C; Musuaya AE; Costa-Junior JM; Castela A; Carpentier J; Faoro V; Klass M; Cnop M; Eizirik DL
Diabetologia; 2023 Mar; 66(3):450-460. PubMed ID: 36401627
[TBL] [Abstract][Full Text] [Related]
16. Interferon alpha: The key trigger of type 1 diabetes.
Lombardi A; Tsomos E; Hammerstad SS; Tomer Y
J Autoimmun; 2018 Nov; 94():7-15. PubMed ID: 30115527
[TBL] [Abstract][Full Text] [Related]
17. Pathological endoplasmic reticulum stress mediated by the IRE1 pathway contributes to pre-insulitic beta cell apoptosis in a virus-induced rat model of type 1 diabetes.
Yang C; Diiorio P; Jurczyk A; O'Sullivan-Murphy B; Urano F; Bortell R
Diabetologia; 2013 Dec; 56(12):2638-46. PubMed ID: 24121653
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokines induce rapid, NO-independent apoptosis, expression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells.
Dettmer R; Niwolik I; Cirksena K; Yoshimoto T; Tang Y; Mehmeti I; Gurgul-Convey E; Naujok O
Diabetologia; 2022 May; 65(5):829-843. PubMed ID: 35122482
[TBL] [Abstract][Full Text] [Related]
19. PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction.
Colli ML; Hill JLE; Marroquí L; Chaffey J; Dos Santos RS; Leete P; Coomans de Brachène A; Paula FMM; Op de Beeck A; Castela A; Marselli L; Krogvold L; Dahl-Jorgensen K; Marchetti P; Morgan NG; Richardson SJ; Eizirik DL
EBioMedicine; 2018 Oct; 36():367-375. PubMed ID: 30269996
[TBL] [Abstract][Full Text] [Related]
20. DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes.
Bugliani M; Syed F; Paula FMM; Omar BA; Suleiman M; Mossuto S; Grano F; Cardarelli F; Boggi U; Vistoli F; Filipponi F; De Simone P; Marselli L; De Tata V; Ahren B; Eizirik DL; Marchetti P
Mol Cell Endocrinol; 2018 Sep; 473():186-193. PubMed ID: 29409957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
